US Healthcare Distribution Giant Executive Buys Back Shares Worth Billions, HR Chief Replacement Ahead

At U.S. healthcare distribution giant Cencora, Inc. (NYSE: COR), a director and an insider have made additional open-market purchases of company stock, and the chief human resources officer is set to be replaced in July, with the incumbent transitioning to an advisory role. Director D. Mark Durcan executed further purchases that boosted his stake’s value to over KRW 10 billion, while another insider modestly increased their holdings.

On June 18, 2026, Durcan acquired 4,000 shares in an open-market transaction for approximately USD 1.1 million (about KRW 1.5 billion), raising his direct stake to roughly 30,000 shares, valued at around USD 8.6 million (approximately KRW 12 billion). Then on June 22, insider Lauren M. Tyler added several hundred shares through multiple transactions of about 55 shares each, investing approximately USD 140,000 (around KRW 200 million) and increasing her direct holdings to about USD 1.18 million (mid-KRW 1 billion range).

In a June 15 announcement, Cencora said that Silvana Battaglia, its chief human resources officer for the past seven years, will retire effective July 13, 2026, and transition to a special advisor role through year-end to support the handover. On the same day, the company named Samantha Hammock—formerly head of HR at Verizon Communications and American Express—as its new CHRO, effective July 13. She will report directly to CEO Robert P. Mauch and join the executive leadership team to oversee global talent and HR strategy.

Most recently, on June 29, 2026, Cencora announced Eva C. Boratto as its new Executive Vice President and Chief Financial Officer, reaffirming its fiscal 2026 and long-term performance guidance. Earlier this year, the company closed a USD 3 billion bond issuance (approximately KRW 4 trillion) to fund the acquisition of oncology-focused services provider OneOncology and for other corporate purposes, underscoring its ongoing engagement in major M&A and financing activities.

Headquartered in Pennsylvania, Cencora is a global pharmaceutical wholesale, distribution, and services company. Formerly AmerisourceBergen, it is a Fortune 500 firm listed on the New York Stock Exchange. The company recently surpassed USD 300 billion in annual revenue (just over KRW 400 trillion), supplying medicines and healthcare solutions to hospitals, pharmacies, and pharmaceutical manufacturers across the U.S. and Europe.